Axsome Therapeutics Inc (NASDAQ: AXSM) is -12.38% lower on its value in year-to-date trading and has touched a low of $55.02 and a high of $98.40 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AXSM stock was last observed hovering at around $69.90 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $69.74, the stock is -12.74% and -18.37% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.88 million and changing -0.23% at the moment leaves the stock -7.44% off its SMA200. AXSM registered 10.05% gain for a year compared to 6-month gain of -9.41%. The firm has a 50-day simple moving average (SMA 50) of $11.48 and a 200-day simple moving average (SMA200) of -$13.80.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -24.41% loss in the last 1 month and extending the period to 3 months gives it a -0.60%, and is -3.19% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.62% over the week and 4.54% over the month.
Axsome Therapeutics Inc (AXSM) has around 545 employees, a market worth around $3.30B and $270.60M in sales. Fwd P/E is 79.70. Profit margin for the company is -88.41%. Distance from 52-week low is 26.75% and -29.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.61%).
Axsome Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$1.21 with sales reaching $73.71M over the same period.The EPS is expected to grow by 29.88% this year, but quarterly earnings will post 40.50% year-over-year. Quarterly sales are estimated to grow 182.70% in year-over-year returns.
337 institutions hold shares in Axsome Therapeutics Inc (AXSM), with institutional investors hold 100.11% of the company’s shares. The shares outstanding are 47.35M, and float is at 38.78M with Short Float at 19.26%. Institutions hold 82.96% of the Float.
The top institutional shareholder in the company is RTW Investments LP with over 4.28 million shares valued at $307.87 million. The investor’s holdings represent 9.08% of the AXSM Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 3.74 million shares valued at $268.95 million to account for 7.93% of the shares outstanding. The other top investors are Blackrock Inc. which holds 2.72 million shares representing 5.77% and valued at over $195.71 million, while Fairmount Funds Management LLC holds 4.97% of the shares totaling 2.34 million with a market value of $168.51 million.
Axsome Therapeutics Inc (AXSM) Insider Activity
The most recent transaction is an insider sale by Coleman Mark, the company’s Director. SEC filings show that Coleman Mark sold 18,572 shares of the company’s common stock on Sep 15 ’23 at a price of $75.18 per share for a total of $1.4 million. Following the sale, the insider now owns 0.4 million shares.
Axsome Therapeutics Inc disclosed in a document filed with the SEC on Sep 15 ’23 that Coleman Mark (Director) sold a total of 11,016 shares of the company’s common stock. The trade occurred on Sep 15 ’23 and was made at $75.19 per share for $0.83 million. Following the transaction, the insider now directly holds 25097.0 shares of the AXSM stock.
